Smartlab Europe

News

AbbVie raises dividend and buys $10 billion of shares

AbbVie Inc (ABBV.N) said on Thursday its board had approved a $10 billion stock repurchase program, and the drugmaker also increased its quarterly dividend, as it reaped the benefits of U.S. tax law changes. The Chicago-based...

FDA approves ODD for selumetinib for treating neurofibromatosis type 1 (NF1): Merck

AstraZeneca and Merck, known as MSD outside the U.S. and Canada, announced that the U.S. FDA has granted Orphan Drug Designation (ODD) for selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1). ...

Merck disappoints by failing in phaseIII study of its drug which cures Alzheimer’s

The drug, verubecestat, was being tested in patients who showed only a glimmer of the symptoms that eventually rob them of memories and basic functions. It’s another setback in a long list of experimental treatments that have had little...

Oxford BioMedia could gain $100 million in sanofi invasion target

UK gene cell therapy designer Oxford BioMedica’s shares jumped  as much as 11.2% to 12.30 pence this morning after announcing a $100 million collaboration and licence agreement with US hemophilia specialist Bioverativ , which last month agreed to be...

Pharma pioneer Sanofi guards its Dengvaxia

You do not get severe dengue from the vaccine. Just because you were administered with the vaccine means you’ll get infected. That’s s a little misinformation,” said Dr. Ruby Dizon, Sanofi Pasteur medical director. “You get...

Pfizer gets BREAKTHROUGH THERAPY designation from FDA for patients suffering with ATOPIC DERMATITIS

Pfizer Inc. (NYSE:PFE) today announced its once-daily oral Janus kinase 1 (JAK1) inhibitor PF-04965842 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with moderate-to-severe atopic dermatitis (AD). ...

Pfizer invests $147M investment in portage

The world's largest pharmaceutical manufacturing plant is now 98,500 square feet larger.And that expansion -- the most visible part of an ongoing $147 million investment by Pfizer Inc. -- is a very good thing for Portage and Kalamazoo County,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »